Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation

Pediatric Nephrology

Volumn 17, Issue 3, 2002, Pages 150-154

  Bunchman, Timothy E ^a   Maxvold, Norma J ^a   Barnett, Joni ^a   Hutchings, Anne ^a   Benfield, Mark R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bicarbonate dialysis; Citrate anticoagulation; Hemofiltration; Normocarb

Indexed keywords

ACD-A; ANTIBIOTIC AGENT; BICARBONATE; CALCIUM; CALCIUM CHLORIDE; CITRIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMODIALYSIS FLUID; MAGNESIUM; NORMOCARB; PHOSPHORUS; POTASSIUM CHLORIDE; SODIUM;

ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY WEIGHT; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIALYSATE; DRUG INDUSTRY; ERROR; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INFANT; MACHINE; MEDICAL DECISION MAKING; NEWBORN; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SEPSIS; STANDARD; TUMOR LYSIS SYNDROME; ULTRAFILTRATION;

ADOLESCENT; ANTICOAGULANTS; BICARBONATES; CHILD; CHILD, PRESCHOOL; CITRIC ACID; DIALYSIS SOLUTIONS; HEMOFILTRATION; HUMANS; INFANT; SEPSIS; TUMOR LYSIS SYNDROME;

EID: 0036944359     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-001-0791-0     Document Type: Article

References (20)

1. Lowrie L (2000) Renal replacement therapies in pediatric multiorgan dysfunction syndrome. Pediatr Nephrol 14:6-12
2. Belsha CW, Kohaut EC, Warady BA (1995) Dialytic management of childhood acute renal failure: a survey of North American pediatric nephrologists. Pediatr Nephrol 9:361-363
3. Parekh RS, Bunchman TE (1996) Dialysis support in the pediatric intensive care unit. Adv Ren Replace Ther 3:326-336
4. Fleming F, Bohn D, Edwards H, Cox P, Geary D, McCrindle BW, William WG (1995) Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis. J Thorac Cardiovasc Surg 109:322-331
5. Smoyer WE, Gardner AV, Mottes TA, Gardner JJ, Brophy PD, McBryde KD, Bunchman TE (2000) Early experience with the safety and effectiveness of the Cobe PRIMSA for pediatric CRRT (abstract). Blood Purif 18:35
6. Mottes TA, Gardner JJ, Kudelka TL, Dorsey LK, Adams BJ, Gardner AV, Brophy PD, Bunchman TE (2000) Conversion from adapted to the Cobe PRISMA system in pediatric CRRT: impact of bedside nursing education and overtime costs (abstract) Blood Purif 18:35
7. Mehta RL, McDonald BR, Aguilar MM, Ward DM (1990) Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38:976-981
8. Runolfur P, Niles JL (1999) Regional citrate anticoagulation in continuous venovenous hemodialysis in critically ill patients. Kidney Int 55:1991-1997
9. Novello A, Kelsch RC, Easterling RE (1976) Acetate intolerance during hemodialysis. Clin Nephrol 5:29-32
10. Maxvold NJ, Flynn JT, Smoyer WE, Borphy PD, Mottes TA, Kudelka TL, Dorsey LK, Gardner JJ, Bunchman TE (1999) Perspective, crossover comparison of bicarbonate versus lactate-based dialysate for pediatric CVVHD. Blood Purif 17:27
11. Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW (1999) Continuous venovenous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transplant 14:2387-2391
12. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE (2000) Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a comparison between CVVH and CVVHD therapies. Crit Care Med 28:1161-1165
13. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 356:26-30
14. Lacour F, Maheut H (1992) AN-69 membrane and conversion enzyme inhibitors: prevention of anaphylactic shock by alkaline rinsing? Nephrologie 13:135-136
15. Brophy PD, Mottes TA, Kudelka TL, McBryde KD, Gardner JJ, Maxvold NJ, Bunchman TE (2001) AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 38:173-178
16. Werner HA, Herbertson MJ, Seear MD (1994) Functional characteristics of pediatric veno-venous hemofiltration. Crit Care Med 22:320-325
17. Gouyon JB, Petion AM, Huet F, Lallemant C (1994) Urea removal by hemofiltration and hemodiafiltration. Biol Neonate 65:36-40
18. Braun N, Rosenfield S, Giolai M, Banzhaf W, Fretschner R, Warth H, Weinstock C, Deppisch R, Erley CM, Muller GA, Risler T (1995) Effect of continuous hemodiafiltration on IL-6, TNF-a, C3a, and TCC in patients with SIRS/septic shock using two different membranes. Contrib Nephrol 116:89-98
19. Bouman CS, Olden RW van, Stoutenbeek CP (1998) Cytokine filtration and adsorption during pre and post dilution hemofiltration in four different membranes Blood Purif 16:261-268
20. Maxvold NJ, Smoyer WE, Gardner JJ, Bunchman TE (1997) Management of acute renal failure in the pediatric patient: hemofiltration versus hemodialysis. Am J Kidney Dis 30:S84-S88